Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor

A N Kingsnorth1

  • 1Dept. of Surgery, Derriford Hospital, University of Plymouth, England, UK.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Platelet-activating factor (PAF) antagonists, like lexipafant, show promise in treating acute pancreatitis. Clinical studies indicate lexipafant reduces organ failure and improves recovery in severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The value and role of mosquito meshes in low resource and poor income settings.

Hernia : the journal of hernias and abdominal wall surgery·2020
Same author

Worldwide hernia repair: variations in the treatment of primary unilateral inguinal hernias in adults in the United Kingdom and in low- and middle-income countries.

Hernia : the journal of hernias and abdominal wall surgery·2019
Same author

Is there a role for hernia subspecialists? Or is this a step too far?

Hernia : the journal of hernias and abdominal wall surgery·2016
Same author

Medical talc increases the incidence of seroma formation following onlay repair of major abdominal wall hernias.

Hernia : the journal of hernias and abdominal wall surgery·2013
Same author

Comment to: the use of sterilized mosquito nets for hernioplasty: a systematic review. Sørensen CG, Rosenberg J. Hernia 2012; 16: 621-625.

Hernia : the journal of hernias and abdominal wall surgery·2013
Same author

Familial female femoral herniation.

Hernia : the journal of hernias and abdominal wall surgery·2013

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Platelet-activating factor (PAF) is a proinflammatory lipid involved in acute pancreatitis.
  • PAF plays a role in pancreatic exocrine secretion and systemic inflammatory responses.

Purpose of the Study:

  • To evaluate the efficacy of the novel PAF antagonist, lexipafant, in treating acute pancreatitis.
  • To assess lexipafant's impact on organ failure and recovery in human patients.

Main Methods:

  • Preclinical studies using experimental acute pancreatitis models.
  • A double-blind, randomized, Phase II clinical trial in human patients with acute pancreatitis.
  • Assessment of organ failure scores and recovery rates.

Main Results:

Related Experiment Videos

  • Lexipafant ameliorated experimental pancreatitis, reducing markers of inflammation and organ damage.
  • In a Phase II trial, lexipafant significantly reduced organ failure scores.
  • Seven of 12 severe acute pancreatitis patients treated with lexipafant recovered, compared to two of 11 on placebo.

Conclusions:

  • Lexipafant demonstrates potential as a therapeutic agent for human acute pancreatitis.
  • Further Phase III clinical trials are ongoing to confirm its efficacy and safety.